Molecular basis for substrate specificity of the Phactr1/PP1 phosphatase holoenzyme
Authors:
- Roman O FedoryshchakRFRoman O Fedoryshchak
- Magdalena PřechováMPMagdalena Přechová
- Abbey M ButlerABAbbey M Butler
- Nicola O'REillyNONicola O'REilly
- Helen R FlynnHFHelen R Flynn
- Ambrosius P SnijdersASAmbrosius P Snijders
- Sila UltanirSUSila Ultanir
- Stephane MouilleronSMStephane Mouilleron
- Richard TreismanRTRichard Treisman
Open Access
- 25 September 2020
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Abstract
PPP-family phosphatases such as PP1 have little intrinsic specificity. Cofactors can target PP1 to substrates or subcellular locations, but it remains unclear how they might confer sequence-specificity on PP1. The cytoskeletal regulator Phactr1 is a neuronally enriched PP1 cofactor that is controlled by G-actin. Structural analysis showed that Phactr1 binding remodels PP1's hydrophobic groove, creating a new composite surface adjacent to the catalytic site. Using phosphoproteomics, we identified mouse fibroblast and neuronal Phactr1/PP1 substrates, which include cytoskeletal components and regulators. We determined high-resolution structures of Phactr1/PP1 bound to the dephosphorylated forms of its substrates IRSp53 and spectrin αII. Inversion of the phosphate in these holoenzyme-product complexes supports the proposed PPP-family catalytic mechanism. Substrate sequences C-terminal to the dephosphorylation site make intimate contacts with the composite Phactr1/PP1 surface, which are required for efficient dephosphorylation. Sequence specificity explains why Phactr1/PP1 exhibits orders-of-magnitude enhanced reactivity towards its substrates, compared to apo-PP1 or other PP1 holoenzymes.Keywords
All Related Versions
Funding Information
- H2020 European Research Council (268690)
- Cancer Research UK (FC001-190)
- Medical Research Council (FC001-190)
- Wellcome Trust (FC001-190)
- Cancer Research UK (FC001-201)
- Medical Research Council (FC001-201)
- Wellcome Trust (FC001-201)
This publication has 71 references indexed in Scilit:
- The serine/threonine kinase Par1b regulates epithelial lumen polarity via IRSp53-mediated cell–ECM signalingJournal of Cell Biology, 2011
- An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma proteinNature Structural & Molecular Biology, 2010
- The extended PP1 toolkit: designed to create specificityTrends in Biochemical Sciences, 2010
- Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sitesNature Structural & Molecular Biology, 2010
- Docking Motif-Guided Mapping of the Interactome of Protein Phosphatase-1Chemistry & Biology, 2009
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- Protein Phosphatase Type 1 Directs Chitin Synthesis at the Bud Neck inSaccharomyces cerevisiaeMolecular Biology of the Cell, 2008
- IRSp53: crossing the road of membrane and actin dynamics in the formation of membrane protrusionsTrends in Cell Biology, 2008
- Structural basis of protein phosphatase 1 regulationNature, 2004
- Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1The EMBO Journal, 1997